TY  - JOUR

T1  - Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables

JO  - Journal of Clinical Pathology

UR  - https://doi.org/10.1136/jcp.2005.030031

PY  - 2006/02/17

AU  - Cross SS

AU  - Harrison RF

AU  - Balasubramanian SP

AU  - Lippitt JM

AU  - Evans CA

AU  - Reed MWR

AU  - Holen I

ED  - 

DO  - DOI: 10.1136/jcp.2005.030031

PB  - BMJ

VL  - 59

IS  - 7

SP  - 716

EP  - 720

Y2  - 2025/10/24

ER  -